Clinical trialNCT05462704RecruitingPhase 3Interventional

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

SponsorWomen and Infants Hospital of Rhode IslandEnrollment300Iron Deficiency AnemiaPregnancy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<30 ng/mL) at 13 - 30 weeks will be effective, safe and cost-effective in reducing severe maternal morbidity-as measured by maternal anemia at delivery-and will also improve offspring neurodevelopment.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Methodius Tuuli, MD, MPH, MBA
Women and Infants Hospital of Rhode Island
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama Medical Center
Birmingham, Alabama, United States
Recruiting
Gnp Research at Heme-on-Call
Miami, Florida, United States
Recruiting
Michigan University Medical Center
Ann Arbor, Michigan, United States
Recruiting
Washington University Medical Center
St Louis, Missouri, United States
Recruiting
Oregon Health and Sciences Uiversity Medical Center
Portland, Oregon, United States
Recruiting
Hasbro Children'S Hospital
Providence, Rhode Island, United States
Recruiting
Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States
Recruiting
University of Utah Hospital
Salt Lake City, Utah, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ferric derisomaltose →Ferrous sulfate

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Jan 2023
Primary completion: 30 Mar 2027
Completion: 31 Mar 2027
Last update posted: 10 Jun 2025
Registered enrollment: 300
Registry id: NCT05462704

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.